CD274 and neoplasm: A variety of tumor cells, such as CRC, lung cancer and leukemia, can avoid the recognition and killing of T cells by overexpressing the programmed death ligand 1 (PD-L1), resulting in T cell exhaustion in the tumor microenvironment (TME) and realizing immune escape [7].